Teva Pharmaceuticals Investor Relations Manager Salaries in Boulder | Comparably
Teva Pharmaceuticals Claimed Company
Teva is a leading global pharmaceutical company that delivers high quality healthcare solutions used by millions of patients every day. read more
EMPLOYEE
PARTICIPANTS
101
TOTAL
RATINGS
763
HR or Marketing? Claim Your Free Employer Account

Teva Pharmaceuticals Investor Relations Manager Salaries in Boulder

The average Teva Pharmaceuticals Investor Relations Manager in Boulder earns an estimated $97,836 annually. Teva Pharmaceuticals' Investor Relations Manager compensation is $10,533 more than the US average for a Investor Relations Manager.

In Boulder, The Communications Department at Teva Pharmaceuticals earns $34,987 more on average than the Business Development Department.

Last updated 9 months ago.

$51k
$64k
$75k
$85k
$114k
$175k
$97,836
Average Compensation
$97,836
avg. base

Investor Relations Manager Salaries at Teva Pharmaceuticals

* estimated salary

Compensation at Teva Pharmaceuticals by Department

In Boulder, The Communications Department averages $34,987 more than the Business Development Department, and $450 less than the Enterprise Risk Department

Enterprise Risk
$185,967 Avg. total comp.
+$450
Communications
$185,517 Avg. total comp.
Business Development
$150,530 Avg. total comp.
-$35k

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to Teva Pharmaceuticals reported making $152,500, while the average male Investor Relations Manager at similar sized companies reported making $75,500.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Investor Relations Manager at companies similar size to Teva Pharmaceuticals reported making $175,000, while the average Caucasian Investor Relations Manager at similar sized companies reported making $70,250.

How Investor Relations Managers at Teva Pharmaceuticals Rate Their Compensation

The majority of Investor Relations Managers at Teva Pharmaceuticals believe they're not compensated fairly. 100% of Investor Relations Managers at Teva Pharmaceuticals say they receive annual bonuses, and the majority (63%) are satisfied with their benefits. See more compensation ratings at Teva Pharmaceuticals

×
Rate your company